| Facial Feminization Surgery ERAS Protocol . |
|---|
| Preoperative |
| Counseling and education regarding postoperative protocol |
| Intraoperative |
| 0.25% bupivacaine with 1:200,000 epinephrine 10 minutes before each incision |
| IV opioids as needed |
| IV ketorolac (15-30 mg) |
| IV acetaminophen (1000 mg) |
| Postoperative |
| Scheduled IV ketorolac (15 mg) and oral acetaminophen (650 mg) every 6 hours until discharge |
| Oral tramadol (50 mg) for breakthrough pain |
| Oral oxycodone (5 mg) or IV hydromorphone based on clinical judgment |
| Post discharge (5-day supply) |
| Acetaminophen (650 mg) and ibuprofen (400 mg) every 6 hours alternating until no longer needed |
| 5-day supply of tramadol (50 mg) for breakthrough pain |
| Facial Feminization Surgery ERAS Protocol . |
|---|
| Preoperative |
| Counseling and education regarding postoperative protocol |
| Intraoperative |
| 0.25% bupivacaine with 1:200,000 epinephrine 10 minutes before each incision |
| IV opioids as needed |
| IV ketorolac (15-30 mg) |
| IV acetaminophen (1000 mg) |
| Postoperative |
| Scheduled IV ketorolac (15 mg) and oral acetaminophen (650 mg) every 6 hours until discharge |
| Oral tramadol (50 mg) for breakthrough pain |
| Oral oxycodone (5 mg) or IV hydromorphone based on clinical judgment |
| Post discharge (5-day supply) |
| Acetaminophen (650 mg) and ibuprofen (400 mg) every 6 hours alternating until no longer needed |
| 5-day supply of tramadol (50 mg) for breakthrough pain |
Information in Table 4 was sourced from Bedar et al.7 ERAS, enhanced recovery after surgery; IV, intravenous.
| Facial Feminization Surgery ERAS Protocol . |
|---|
| Preoperative |
| Counseling and education regarding postoperative protocol |
| Intraoperative |
| 0.25% bupivacaine with 1:200,000 epinephrine 10 minutes before each incision |
| IV opioids as needed |
| IV ketorolac (15-30 mg) |
| IV acetaminophen (1000 mg) |
| Postoperative |
| Scheduled IV ketorolac (15 mg) and oral acetaminophen (650 mg) every 6 hours until discharge |
| Oral tramadol (50 mg) for breakthrough pain |
| Oral oxycodone (5 mg) or IV hydromorphone based on clinical judgment |
| Post discharge (5-day supply) |
| Acetaminophen (650 mg) and ibuprofen (400 mg) every 6 hours alternating until no longer needed |
| 5-day supply of tramadol (50 mg) for breakthrough pain |
| Facial Feminization Surgery ERAS Protocol . |
|---|
| Preoperative |
| Counseling and education regarding postoperative protocol |
| Intraoperative |
| 0.25% bupivacaine with 1:200,000 epinephrine 10 minutes before each incision |
| IV opioids as needed |
| IV ketorolac (15-30 mg) |
| IV acetaminophen (1000 mg) |
| Postoperative |
| Scheduled IV ketorolac (15 mg) and oral acetaminophen (650 mg) every 6 hours until discharge |
| Oral tramadol (50 mg) for breakthrough pain |
| Oral oxycodone (5 mg) or IV hydromorphone based on clinical judgment |
| Post discharge (5-day supply) |
| Acetaminophen (650 mg) and ibuprofen (400 mg) every 6 hours alternating until no longer needed |
| 5-day supply of tramadol (50 mg) for breakthrough pain |
Information in Table 4 was sourced from Bedar et al.7 ERAS, enhanced recovery after surgery; IV, intravenous.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
